Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Pediatrics|January 28, 2015
Sustained lung inflation at birth for preterm infants: a randomized clinical trialGianluca Lista, Luca Boni, Fabio Scopesi, et al.
Translational Oncology|February 28, 2020
hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer PatientsJessica Iorio, Elena Lastraioli, Lorenzo Tofani, et al.
The American Journal of Cardiology|March 18, 2014
Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factorsPaolo Spirito, Camillo Autore, Francesco Formisano, et al.
The Oncologist|March 11, 2018
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03)Carmine Pinto, Maurizio Di Bisceglie, Francesca Di Fabio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancerMarcello Tiseo, Marzia Capelletti, Giuseppe De Palma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) studyAndrea Ardizzoni, Adolfo Favaretto, Luca Boni, et al.
Tumori|December 16, 2024
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi, et al.
Clinical Lung Cancer|December 3, 2014
Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trialMarcello Tiseo, Luca Boni, Francesca Ambrosio, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE studyGiuseppe Lamberti, Karim Rihawi, Francesca Mazzoni, et al.
NPJ Breast Cancer|March 26, 2021
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trialAndrea DeCensi, Harriet Johansson, Thomas Helland, et al.
Pageof 15